Clinical Trials Logo

Vaginal Infection clinical trials

View clinical trials related to Vaginal Infection.

Filter by:

NCT ID: NCT02308033 Completed - Vaginal Infection Clinical Trials

Multi-Center Study of New Medications to Treat Vaginal Infections

SMART GIVES
Start date: June 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of metronidazole gel in the treatment of vaginal infections.

NCT ID: NCT02308007 Completed - Vaginal Infection Clinical Trials

Multi-Center Study of New Medications to Treat Vaginal Infections

SMART GIVES
Start date: June 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of terconazole/metronidazole gel in the treatment of vaginal infections

NCT ID: NCT01843166 Completed - Quality of Life Clinical Trials

Vaginal Estrogen With Pessary Treatment

Start date: July 2012
Phase: N/A
Study type: Interventional

Patients presenting with pelvic organ prolapse will be offered the use of a pessary. Vaginal estrogen cream treatment with the pessary will be randomized amongst the patients and patient satisfaction and complication rates will be assessed during follow-up.

NCT ID: NCT01812889 Completed - Vaginal Infection Clinical Trials

Evaluation of Intravaginal Gel and Ovule Formulations of TOL-463

Start date: April 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the safety, local tolerability and pharmacokinetic parameters of TOL-463 intravaginal dosage forms in both healthy, nonpregnant females following single dose administration (Part 1), and in nonpregnant women with vaginitis following multi-dose administration (Part 2).

NCT ID: NCT01599416 Completed - Clinical trials for Human Papillomavirus

Influence of U-relax on Vaginal Health Promotion and HPV DNA Test Change From Positive to Negative

Start date: June 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to understand the effect of using oral U-relax on HPV infected women for vaginal environment health promotion, and the HPV DNA Test Index change from positive to negative. Long-term infection of HPV is associated with cervical cancer. U-relax contains Lactobacillus GR-1 and Lactobacillus RC-14 and has been approved of its benefits on treatment of BV, UTI, IBD and can improve vaginal environment health. Patients with positive result of HPV DNA test have no appropriate and aggressive treatment to reduce the risk of cervical cancer. This clinical trial tries to reveal the influence of oral U-relax and patients with HPV DNA test positive result.

NCT ID: NCT01055106 Completed - Vaginal Infection Clinical Trials

Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis

Start date: January 2010
Phase: Phase 2
Study type: Interventional

The objective of this study is to evaluate the efficacy and safety of GW05 administered in 3 regimens versus metronidazole 0.75% for the treatment of bacterial vaginosis.

NCT ID: NCT00694928 Completed - Vaginal Infection Clinical Trials

Vaginal Infection Study 2

Start date: May 2008
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of a vaginal product compared with that of another vaginal product in the treatment of vaginal infections.

NCT ID: NCT00324246 Completed - Vaginal Infection Clinical Trials

Feasibility Study of the NEW NORMA-SENSE

Start date: September 2006
Phase: Phase 3
Study type: Observational

- In-vitro study - Collect data regarding the color appearance on the new developed indicator strips (NEW NORMA-SENSE), in contact with vaginal secretion with elevated pH - Measure the buffering capacity of vaginal secretion from non-symptomatic and symptomatic subjects - Detect these indicator strips' performance, in contact with urine